Delivery Order SPE2DB22D1200-SPE2DB25FN3VR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Methimazole 5 mg tablets in quantities of 90 units, with a ceiling value of $1,475.78. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a continuation of pharmaceutical support under AmerisourceBergen's broader federal contracting relationship. The award carries no set-aside designation and was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $1,557.34 to AmerisourceBergen Drug Corp for the supply of Methimazole 5 mg tablets in quantities of 90 units. This firm fixed price delivery order, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive procurement. The contractor will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,250 units of Methimazole 5 mg tablets. The contract has a ceiling value of $1,351.32 and a period of performance through May 15, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,567,016,240 units of Methimazole 10 mg tablets. The firm-fixed-price delivery order contract, valued at $1,178.78, has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,531,006 units of the pharmaceutical product methimazole 5 mg tablets. The fixed-price, firm-fixed delivery order contract, valued at $1,816.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical on May 7, 2024 and has an ultimate completion date of May 8, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 4,564,054,769 units of the pharmaceutical product methimazole 5 mg tablets. The total ceiling value of the contract is $2,674.19 and the period of performance runs through March 25, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract...
- The Defense Logistics Agency awarded a $136,890 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 boxes of 5 mg methimazole tablets. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for shipment of the pharmaceutical products to a facility in Conshohocken, Pennsylvania by September 22, 2023. As a major provider of medical supplies to the U.S. Department of Defense, Amerisourcebergen will fulfill this order from its...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Methimazole 10 mg tablets. The contract has a firm fixed price of $4,211.99 and a period of performance through September 17, 2024. The contract is not set aside for any specific business size or type. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through...
- This federal contract award, valued at $31,972.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,690 units of the pharmaceutical product Methimazole 5 mg Tablet in 100 count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of May 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,071.76 delivery order is for the supply of Methimazole 10 mg tablets, a medication commonly used to treat hyperthyroidism. The contract is a firm-fixed-price, non-set-aside award with a completion date of December 5, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB25FN3VRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,099.94 to AmerisourceBergen Drug Corp for the supply of Methimazole 5 mg tablets (180-count units) with an ultimate completion date of August 15, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on August 14, 2025, with performance originating from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply chain requirements. This award is a child delivery order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a robust federal contract portfolio with DLA and has demonstrated significant capability in fulfilling competitive medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 8/14/25 |